Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia. - Wikidata - awgldk - TriplyDB

Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia.

Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia.

http://www.wikidata.org/entity/Q33340612

about

The prion hypothesis in Parkinson's disease: Braak to the future The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia Neuropathology of non-Alzheimer degenerative disorders Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition Glia and alpha-synuclein in neurodegeneration: A complex interaction The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies.Oculo-Visual Dysfunction in Parkinson's Disease.Epidemiological pathology of dementia: attributable-risks at death in the Medical Research Council Cognitive Function and Ageing Study Neuropathologic substrates of Parkinson disease dementia.Comparison of risk factor profiles in incidental Lewy body disease and Parkinson disease.Seeding and transgenic overexpression of alpha-synuclein triggers dendritic spine pathology in the neocortex Low sensitivity in clinical diagnoses of dementia with Lewy bodies Embryonic development of selectively vulnerable neurons in Parkinson's disease.Parkinson's disease dementia: a diminished role for the Lewy body.Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?Disentangling the relationship between lewy bodies and nigral neuronal loss in Parkinson's disease.Lewy bodies.Exploring Braak's Hypothesis of Parkinson's Disease.Association between male gender and cortical Lewy body pathology in large autopsy series.Alpha-synuclein aggregation induced by brief ischemia negatively impacts neuronal survival in vivo: a study in [A30P]alpha-synuclein transgenic mouse Parkinson's disease, cortical dysfunction, and alpha-synuclein.Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson's disease and incidental Parkinson's disease.Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats.Alpha-synucleinopathy and neuropsychological symptoms in a population-based cohort of the elderly.Aggregation of α-synuclein in brain samples from subjects with glucocerebrosidase mutations.Incidental Lewy body disease: do some cases represent a preclinical stage of dementia with Lewy bodies?Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies.Prion-like propagation of human brain-derived alpha-synuclein in transgenic mice expressing human wild-type alpha-synuclein.Understanding the susceptibility of dopamine neurons to mitochondrial stressors in Parkinson's disease.Applicability of current staging/categorization of alpha-synuclein pathology and their clinical relevance.Arrestins and two receptor kinases are upregulated in Parkinson's disease with dementia.Lewy pathology is not the first sign of degeneration in vulnerable neurons in Parkinson disease.Idiopathic REM sleep behaviour disorder in the development of Parkinson's disease Cell therapy for Parkinson's disease: only young onset patients allowed? Reflections about the results of recent clinical trials with cell therapy and the progression of Parkinson's disease.Classical Parkinson disease versus Parkinson complex--reflections against staging and in favour of heterogeneity.Age and apoE associations with complex pathologic features in Alzheimer's disease.Staging of neurofibrillary pathology in Alzheimer's disease: a study of the BrainNet Europe Consortium Impulsivity and apathy in Parkinson's disease.Examination of the clinicopathologic continuum of Alzheimer disease in the autopsy cohort of the National Alzheimer Coordinating Center.

P2860

Q22001062-16F1BCB1-1354-4796-A79B-20983ED87DE1 Q22252705-7EB9896A-3CCB-458E-808E-FBDEB08B82E2 Q24657571-183E67B9-C5CA-4E3A-906E-9DBBF609A552 Q24813664-CFCE85B3-F4A2-4D6F-84D7-A1F4A3BC5E2A Q26851153-9BBC3EB7-6BE0-4DF7-AB29-950B7696DA05 Q27004240-DA845952-A380-422E-B0DD-48CE8C4A39EA Q27686837-54D0B8F6-6065-4391-8CDA-CD0338E3B616 Q27691337-56F769D0-B873-46D8-9D9B-A99F55815009 Q28471701-2ED3D253-ADB0-443B-AB9E-EBF5BE28A0AF Q30527797-5C6BB55F-813F-4BBE-BDDB-59CE579B7C31 Q33619119-F2C6ADF2-22F4-4903-9553-C02583FFD238 Q33625757-189C56C2-8FB6-48BA-B509-DFF80402EE96 Q33729642-412268B0-2E56-4FA9-8F80-B3AC434685CE Q33835242-B73260D3-AE85-42AF-BB5D-E95219953639 Q34024575-BF102465-A3F8-49E3-BB64-B89CCF872634 Q34327102-039D0BF0-8947-4C92-91F6-1201528D5B4B Q34336792-1966132B-3867-446C-80B7-7CE935224C18 Q34478663-329F6067-9762-4C37-844A-E3548C8DF4C9 Q34552244-DA5E3C55-2F0B-4ED0-9D79-F95A6A535197 Q34581052-CC794B35-AC5E-4743-B100-00849582CB48 Q34714740-B55FFA36-30CD-4B24-824D-CA30B01FDF14 Q35161124-C62D35AA-53D7-4732-B897-6516A0721B7C Q35287117-1CD2E25B-E312-4D22-A75C-09DF2C70F3EB Q35313910-83E87105-C178-48BF-8F19-FF239F4DA266 Q35380017-E0612102-E5BF-4629-B227-9AC74C6C82D0 Q35960402-A868C05B-6C3A-4D04-8A13-D3319D17C4B9 Q36004679-DB03E61C-BB62-4A3C-AB32-8BF8AA7AFDDA Q36315342-C0A16DB4-E10A-44BB-8C03-5DAEBCB0BBB0 Q36321556-0C97B54E-4600-4DBF-B86B-68515E172713 Q36372732-FC3264B0-60A7-46E0-BF9C-C559C062471C Q36501660-8E24CBAD-65A6-4229-9C25-E31222991EBB Q36510471-BF7E4445-7DAC-44C0-BB71-A0E21268303E Q36626757-DF16921B-C75D-459D-AFD5-996B4B7B4A3E Q36656691-584BADB1-3632-4271-93C1-6F1A7E3B75C7 Q36660994-5C9DBD60-0B08-4782-9DF4-0DF29A0EC5CF Q36861710-3FF1655A-47C6-418D-8DA1-45B1552ACFB0 Q36942274-6369DC38-F32E-488F-AF0B-A2CC2E0E7235 Q37137198-37CFD45C-707D-4D32-9C5D-4BE02ED7500C Q37331607-D424CB0D-2943-4BA4-A6EC-1240CDC5FF75 Q37656915-8BECB65D-4257-411A-BC13-3D4998528287

P2860

Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia.

http://www.wikidata.org/entity/Q33340612

description

2005 nî lūn-bûn

@nan

2005 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia.

@ast

Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia.

@en

type

label

Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia.

@ast

Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia.

@en

prefLabel

Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia.

@ast

Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia.

@en

P1433

Q33340612-AB71A744-0160-400F-B5CD-47F365F8ED08

P1476

Q33340612-5D40D671-F6E6-4644-90BD-FAEB5F32B966

P2093

Q33340612-2390237D-84C0-4558-90F0-32CCC9DE2530

Q33340612-6E813865-9D36-402A-87A9-622803B7D760

Q33340612-B5F76A52-6806-4191-A947-649E8C53966D

Q33340612-EC9652E6-F63C-436D-8CCF-CA26A9B2238B

Q33340612-F27CD140-927C-48E2-97EF-34D0B469940E

P2860

Q33340612-33E67568-6A17-4FC8-A704-372115396BE0

Q33340612-565104E3-D0A1-4829-88DA-B768704C8F9C

Q33340612-58E1F859-03D5-4884-A1A0-D7E266E9617B

Q33340612-5904A532-92CD-44BA-BACB-BE6C9ADA1E9A

Q33340612-5F7DA479-0F73-4957-AF74-9CD896B26F49

Q33340612-665E016B-6EBB-4C5E-92D5-CC9412126849

Q33340612-714F29A9-899B-446D-80C9-7CC66AB9BA68

Q33340612-8F555D59-0F63-4C70-BD0D-5D3EBA39F45B

Q33340612-FC4038AF-34CD-44E8-968B-DA943871E129

P304

Q33340612-CC5FD2A2-7947-43D6-A352-AA1281301A41

P31

Q33340612-34337564-D74E-490E-B921-BBEE9E9C9BEA

P356

Q33340612-8E3B2237-083E-42B3-B167-96C676545E6F

P433

Q33340612-A05ECA0D-E472-4095-883A-565661514437

P478

Q33340612-4328703F-A662-4118-BE01-3D71B96BBE4F

P577

Q33340612-3AE999B1-7DC6-4DA8-B3C3-EA5ECF445C2D

P698

Q33340612-603BCD1E-A542-4053-802E-2BC7B10DB966

P921

Q33340612-1B54084B-E269-4F63-BAD9-4C849D176953

Q33340612-2c329b0e-80bf-4144-9d8c-44eca35b63bc

Q33340612-7EEF57E3-42E8-4745-93B8-F400CD08353B

P356

P1433

Annals of Neurology

P1476

Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia.

@en

P2093

Irina Alafuzoff

http://www.w3.org/2001/XMLSchema#string

Jaana M Autere

http://www.w3.org/2001/XMLSchema#string

Laura Parkkinen

http://www.w3.org/2001/XMLSchema#string

Tarja Kauppinen

http://www.w3.org/2001/XMLSchema#string

Tuula Pirttilä

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies.

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop.

Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes.

Regional distribution of alpha-synuclein pathology in unimpaired aging and Alzheimer disease.

The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity.

Morphogenesis of Lewy bodies: dissimilar incorporation of alpha-synuclein, ubiquitin, and p62.

Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: light and electron microscopic immunocytochemistry of CA2-3 neurites specific to DLBD.

Concentric hyalin intraneuronal inclusions of Lewy type in the brains of elderly persons (50 incidental cases): relationship to parkinsonism.

P304

82-91

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.20321

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P577

2005-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15562510

http://www.w3.org/2001/XMLSchema#string

P921